Together with an interdiziplinary team he uncovered the molecular mechanisms of Alzheimer's disease and identified target molecules for therapeutic treatment.We would Beryllium pleased if you would allow a cookie to Beryllium Garnitur for analysis purposes in order to optimise ur provided information. All data are pseudonymous and
Together with an interdiziplinary Mannschaft he uncovered the molecular mechanisms of Alzheimer's disease and identified target molecules for therapeutic treatment.We would be pleased if you would allow a cookie to Beryllium Reihe for analysis purposes hinein order to optimise ur provided information. All data are pseudonymous and
81377 München christian.haass(at)dzne.de +49 89 4400-46549 Areas of investigation/research focus Prof. Haass started to work on Alzheimer's disease (AD) in 1990 at a time, when very little was known about the cellular mechanisms involved. Based on the pathology, which shows invariably the accumulation and deposition of Amyloid ß-peptide (A